R. Yeh

发表

Use/misuse of over-the-counter medications and associated adverse drug events among HIV-infected patients.

S. Sansgiry, Elizabeth Ajuoga, C. Ngo, 2008, Research in social & administrative pharmacy : RSAP.

Accurate targeting of daily intravenous busulfan with 8-hour blood sampling in hospitalized adult hematopoietic cell transplant recipients.

D. Blough, G. McDonald, J. McCune, 2012, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Impact of Over-the-Counter Medication Misuse and Adverse Drug Events on HIV Patients' Health-Related Quality of Life

S. Sansgiry, Elizabeth Ajuoga, C. Ngo, 2008 .

Efficacy of Pharmacokinetics-Directed Busulfan, Cyclophosphamide, and Etoposide Conditioning and Autologous Stem Cell Transplantation for Lymphoma: Comparison of a Multicenter Phase II Study and CIBMTR Outcomes.

P. Bierman, I. Flinn, C. Flowers, 2016, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Lopinavir/Ritonavir Dosage Form Affects Quality of Life During Monotherapy in HIV-Positive Adults

J. Nemecek, J. Gathe, R. Yeh, 2010, Journal of the International Association of Physicians in AIDS Care.

49th ICAAC Annual Meeting: optimization of anti-infective use in the clinical setting

H. Palmer, R. Jain, R. Yeh, 2009, Expert review of anti-infective therapy.

Lopinavir/Ritonavir Induces the Hepatic Activity of Cytochrome P450 Enzymes CYP2C9, CYP2C19, and CYP1A2 But Inhibits the Hepatic and Intestinal Activity of CYP3A as Measured by a Phenotyping Drug Cocktail in Healthy Volunteers

V. Gaver, J. Eron, A. Kashuba, 2006, Journal of acquired immune deficiency syndromes.

Targeted Busulfan therapy with a steady-state concentration of 600–700 ng/mL in patients with sickle cell disease receiving HLA-identical sibling bone marrow transplant

A. Kassim, H. Frangoul, R. Ho, 2014, Bone Marrow Transplantation.

Safety and efficacy of targeted-dose busulfan and bortezomib as a conditioning regimen for patients with relapsed multiple myeloma undergoing a second autologous blood progenitor cell transplantation.

G. Tricot, D. Reece, D. White, 2014, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Wait and watch approach in managing acute otitis media: current awareness, attitude and their relationship with the behaviour among primary care physicians

S. Sansgiry, Elizabeth A. Coyle, R. Yeh, 2011 .

Antiretroviral drug exposure in the female genital tract: implications for oral pre- and post-exposure prophylaxis

Myron S. Cohen, P. Stewart, B. Jung, 2007, AIDS.

Graft Versus Host Disease Prophylaxis With Abatacept Reduces Severe Acute Graft Versus Host Disease in Allogeneic Hematopoietic Stem Cell Transplant for Beta Thalassemia Major with Busulfan, Fludarabine, and Thiotepa.

S. Davies, C. Dandoy, P. Khandelwal, 2020, Transplantation.

Impact of Sample Size on the Performance of Multiple-Model Pharmacokinetic Simulations

Vincent H. Tam, V. Tam, R. Leary, 2006, Antimicrobial Agents and Chemotherapy.

Genital Tract, Cord Blood, and Amniotic Fluid Exposures of Seven Antiretroviral Drugs during and after Pregnancy in Human Immunodeficiency Virus Type 1-Infected Women

S. Fiscus, A. Horton, M. Vourvahis, 2009, Antimicrobial Agents and Chemotherapy.

Full Validation of an Analytical Method for the HIV-Protease Inhibitor Atazanavir in Combination With 8 Other Antiretroviral Agents and its Applicability to Therapeutic Drug Monitoring

A. Kashuba, N. Rezk, R. Crutchley, 2006, Therapeutic drug monitoring.

Phase I Study of Veliparib (ABT-888) Combined with Cisplatin and Vinorelbine in Advanced Triple-Negative Breast Cancer and/or BRCA Mutation–Associated Breast Cancer

H. Linden, P. Porter, E. Swisher, 2016, Clinical Cancer Research.

Phase I: Veliparib with cisplatin (CP) and vinorelbine (VNR) in advanced triple-negative breast cancer (TNBC) and/or BRCA mutation-associated breast cancer.

H. Linden, P. Porter, E. Swisher, 2014 .

Harmonization of Busulfan Plasma Exposure Unit (BPEU): A Community-Initiated Consensus Statement.

A. Paci, M. Perales, V. Seewaldt, 2019, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Pharmacokinetic-Directed Dose Adjustment Is Essential for Intravenous Busulfan Exposure Optimization: Findings From a Multi-Center Phase II Study of Autologous Hematopoietic Stem Cell Transplantation for Lymphoma in North America

P. Bierman, I. Flinn, T. Shea, 2013 .

Quality Control of Busulfan Plasma Quantitation, Modeling and Dosing: An Interlaboratory Proficiency Testing Program.

E. V. van Maarseveen, J. Ritchie, J. McCune, 2021, Therapeutic drug monitoring.

The association of pharmacy drug‐delivery services with adherence in an urban HIV population

S. Sansgiry, R. Yeh, Shailendra Gupta, 2012 .

Significant publications on infectious diseases pharmacotherapy in 2009.

V. Tam, K. Garey, Elizabeth B. Hirsch, 2010, American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists.

Significant publications on infectious diseases pharmacotherapy in 2007.

V. Tam, K. Garey, K. Kuper, 2008, American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists.

Symposium on roles of and cooperation between academic- and practice-based pharmacy clinicians.

K. Garey, K. Birtcher, Elizabeth A. Coyle, 2010, American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists.

A dose response for radiation-induced intrachromosomal DNA rearrangements detected by inverse polymerase chain reaction.

W. Dewey, H. Forrester, R. Yeh, 1999, Radiation research.

Unreported use of an herbal supplement resulting in decreased clearance of intravenous busulfan in a patient undergoing auto-SCT

I. Braunschweig, S. Barta, J. Carter, 2014, Bone Marrow Transplantation.